Ozone therapy induced sinus arrest in a hypertensive patient with chronic kidney disease: A case report
Tang WJ, Jiang L, Wang Y, et al. Medicine (Baltimore), 2017.
- Study type
- Case report
- People studied
- 1 person
- Population
- 54-year-old woman with hypertension, diabetes, and chronic kidney disease
- Published
- 2017, Medicine (Baltimore)
- Identifiers
- PMID 29390373, DOI 10.1097/MD.0000000000009265
What the authors reported
A patient using ozone autohemotherapy for hypertension and diabetes developed sudden dizziness from hyperkalemia that progressed to sinus arrest; the arrhythmia resolved after stopping ozone therapy and treating the hyperkalemia.
What limits this result
Single case report; the association between ozone autohemotherapy and hyperkalemia-induced sinus arrest is based on temporal sequence, not confirmed mechanistic causation.
Harms reported after ozone therapy, and studies of how ozone exposure affects health. One study rarely settles a medical question; our guides weigh each paper against the rest of the evidence.
Where we cite this study
EBO2 (EBOO) vs Plasmapheresis: Similar Machines, Very Different Medicine
EBO2 (EBOO) and plasmapheresis both draw blood through a machine and return it, but only one is an FDA-regulated therapy with graded indications.
EBO2 (EBOO) Side Effects and Safety: What the Evidence Shows
What clinics and the small EBOO research base report about side effects, the risks that come with any extracorporeal circuit, and what regulators have said.
What Is EBO2 (EBOO) Therapy? Procedure, Evidence, Cost, and Safety
A neutral, sourced explainer of EBO2 (also called EBOO): how the procedure works, what the research shows, typical cost, and the FDA's position.